David Liew drdavidliew
4 years 10 months ago
In ANCA-associated vasculitis, does reverse seroconverting (ANCA+➡️ANCA-) make a difference?
relapse - no
ESRD - no
death - no
Don't measure serial ANCAs for prognosis
(no diff MPO/PR3, RTX/CYC)
target trial emulation @BrighamWomens @MGHrheumatology #ACR21 ABST0419 @RheumNow https://t.co/rLkTY0ul8f
Md Yuzaiful Md Yusof Yuz6Yusof
4 years 10 months ago
Either we need to review the Yearly PAP cervical screening in SLE women or work hard to improve patient awareness. Suspect the latter as time between tests was over 4 years late 😱 and 2.7% developed cancer #ACR21 #Abstr0133 @RheumNow https://t.co/wm01MfoFjf https://t.co/blD8WafZsE
Eric Dein ericdeinmd
4 years 10 months ago
#ACR21 Abst #0269: VA study of AutoAbs and CVD risk
⭐️Anti-malondialdehyde acetaldehyde (anti-MAA) shown to associate w/ CVD risk in non-RA pt
Findings: RF, CCP, anti-IgG anti-MAA, anti-IgM anti-MAA (not IgA) associated with ⬆️ CVD death
https://t.co/WRBh673u8T @Rheumnow #ACRbest
TheDaoIndex KDAO2011
4 years 10 months ago
Dr. M Clowse (on HCQ during pregnancy):
👉All pregnant women get HCQ 400 mg/day regardless of how big they are (she does not dose based on mg/kg/d)
👉with maternal metabolism/volume distrib, levels are low.
#ACR21 @rheumnow #pregnancy @drbags71 https://t.co/dZtFLdKOvk
Dr. John Cush RheumNow
4 years 10 months ago
Industry Press Releases - BMS, Abbvie, UCB, Janssen
The pharmaceutical companies will feature the results of their pivotal clinical trials and data analyses at #ACR21.
https://t.co/RZwtACFZq7 https://t.co/guBG6PDVfp
Patients with rheumatic diseases – requiring lifelong immunosuppressants— are at high risk for respiratory and viral infections. Over the past decade, an armamentarium of biologic and targeted therapies has led to better control of disease activity in patients with rheumatoid arthritis. Whether these patients, especially those receiving newer biological and targeted therapies such as JAK inhibitors, are at an increased risk of severe COVID-19
Dr. John Cush RheumNow
4 years 10 months ago
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow and its Faculty.
Eric Dein ericdeinmd
4 years 10 months ago
@DoctorYasmin: "Where do people go when their doctors don't believe them?". Communicate the unknown and listen. @DrDavidKarp: "It all begins with empathy." Listen to the patient, and you can avoid them from seeking misinformation to fill in gaps #ACR21 @rheumnow https://t.co/nBBDxl2L1D
Dr. Rachel Tate uptoTate
4 years 10 months ago
“It all begins with empathy!” Dr. Karp regarding difficult unknown/long haul COVID19 symptoms in our patients. #ACR21 @RheumNow
sheila RHEUMarampa
4 years 10 months ago
Interesting twist to an #ACR21 keynote lecture: Q&A!👏👏@DoctorYasmin
She even eloquently explained the etymology of crisis-the point in a pt's illness where they might rapidly deteriorate or recover, an inflection point (so relevant now) 👉to a new BETTER normal
@RheumNow https://t.co/UMKIC1tNos
Meral K. El Ramahi, MD MeralElRamahiMD
4 years 10 months ago
How do you separate the misinformation in this ecosystem of cash hungry platforms? Check out
@DoctorYasmin's upcoming book: "What the Fact" for tools on how to handle sifting through the nonsense! #ACR21 @RheumNow https://t.co/oroHMakVT6
TheDaoIndex KDAO2011
4 years 10 months ago
@DoctorYasmin emphasizes our focus should be on:
1 Moral injury, burnout & mental health for providers
2. Providers should make concerted efforts to learn how to communicate in the public space
3. How to institute cultural change
@DrDavidKarp #ACR21 @rheumnow https://t.co/YH7tDeaki3
